Cerevel options trading surge before AbbVie deal news raises eyebrows
By Saqib Iqbal Ahmed NEW YORK (Reuters) -Trading in the options of Cerevel Therapeutics Holdings Inc experienced an unusual surge along with its stock price [more…]
By Saqib Iqbal Ahmed NEW YORK (Reuters) -Trading in the options of Cerevel Therapeutics Holdings Inc experienced an unusual surge along with its stock price [more…]
By Nick Carey and Paul Lienert LONDON/DETROIT (Reuters) – The rise of inexpensive Chinese electric vehicles has upped the pressure on legacy automakers who have [more…]
By Nate Raymond BOSTON (Reuters) – American Airlines has asked a U.S. appeals court to reverse a judge’s decision that sided with the U.S. Department [more…]
By Granth Vanaik (Reuters) -Dollar General on Thursday warned of constrained customer spending, especially in categories such as clothes and home goods, heading into the [more…]
By Laurie Chen BEIJING (Reuters) -China and the European Union agreed their trade relationship should be more balanced at their first in-person summit for four [more…]
(Reuters) -Robinhood Markets on Thursday launched crypto trading for customers in the European Union, expanding into a market with greater regulatory clarity at a time [more…]
(Reuters) -Elon Musk’s artificial intelligence startup xAI has filed with the U.S. securities regulator to raise up to $1 billion in an equity offering, according [more…]
By David Shepardson WASHINGTON (Reuters) – The U.S. Transportation Department is awarding $3 billion for a $12 billion Las Vegas to Southern California high-speed rail [more…]
By Nupur Anand NEW YORK (Reuters) – PNC Financial Services CEO William Demchak on Tuesday said that the market disruptions caused by the Basel III [more…]
By Patrick Wingrove and Bhanvi Satija (Reuters) -Johnson & Johnson on Tuesday forecast revenue growth of 5-6% for 2024, its first full year after hiving [more…]